RELATING TO INSURANCE -- INSURANCE COVERAGE FOR MENTAL ILLNESS AND, SUBSTANCE USE DISORDERS
Impact
The bill amends existing provisions to reflect that there should be no stricter qualitative and quantitative treatment limitations on mental health and substance use disorders than those applied to other medical conditions. By doing so, H7945 encourages insurance companies to adhere to generally accepted standards of care, which aligns healthcare policies with the latest practices in mental health treatment. This could potentially increase access to necessary treatment for individuals struggling with mental health or substance use issues, thereby aiming to improve overall public health outcomes.
Summary
House Bill H7945 seeks to enhance the insurance coverage for the treatment of mental health issues and substance use disorders by ensuring that such coverage is equivalent to other medical conditions. The proposed legislation mandates that both group health plans and individual health insurance plans provide financial coverage for mental health and substance use disorders without imposing annual or lifetime dollar limits. Furthermore, it aims to align the financial and treatment limitations of mental healthcare with those typical for physical health treatments, thereby standardizing care across both spectrums.
Contention
While the bill garners support from numerous mental health advocacy groups that advocate for greater parity in healthcare, there may be points of contention regarding the financial implications for insurers. Concerns have been raised that increased coverage requirements could lead to higher insurance premiums, affecting the affordability of insurance plans under these regulations. Opponents may claim that while well-intentioned, the bill could create an economic burden on the health system and lead to unintended consequences, such as reduced availability of some mental health services or a realignment in how insurance providers manage their portfolios.
Authorizes emergency medical service agencies to transport individuals to alternative facilities for treatment and permits licensed providers for mental health disorders to treat patients within the community.
Mandates all insurance contracts, plans or policies provide insurance coverage for the expense of diagnosing and treating infertility, for women between the ages of 25 and 42 years including preimplantation genetic diagnosis (PGD) in conjunction with IVF.
Residential Substance Use Disorder Treatment Act of 2023 This bill revises and reauthorizes through FY2027 grants for residential substance use disorder treatment programs at state and local correctional and detention facilities. Among the revisions, the bill replaces statutory references to substance abuse with substance use disorder, specifies that the term residential substance use disorder treatment program includes a medication-assisted treatment program, requires the chief medical officer or other staff overseeing a program to complete training on the science of addiction and the latest research and clinical guidance on treating substance use disorders in criminal justice settings, and allows people who are awaiting trial or in pretrial detention to participate in the programs.
Requiring licensure of outpatient substance use disorder treatment facilities and relative to complaint investigation of treatment facilities by the department of health and human services office of the ombudsman and making an appropriation therefor.
Establishing the Nonnarcotic Medication Substance Use Disorder Treatment Program; in organization and jurisdiction of courts of common pleas, providing for court assessments for substance use disorder treatment; in other criminal provisions, further providing for supervisory relationship to offenders; and, in Pennsylvania Board of Probation and Parole, further providing for supervisory relationship to offenders.